Bromocriptine is still approved for use in Australia as an agent to
suppress lactaiton. There was a recent death reported in a thirty year old
women who was given the drug to suppress lactation. A summary of the report
is given below:
Fatal Myocardial Infarction Associated with Bromocriptine for Postpartum
Lactation Suppression

A recent Australian report linked the postpartum use of Bromocriptine to a
fatal myocardial infarction in a 30 year old woman. The patient was given
bromocriptine on the third postpartum day to suppress lactation. She
collapsed 9 hours after the first 2.5 mg dose and was unable to be
resuscitated.
Bromocriptine has been withdrawn from use for lactation suppression in the
USA because of concerns regarding its safety. Its efficacy when compared to
non-pharmacological methods such as analgesia and breast binders has also
been severely questioned. Bromocriptine continues to be available for this
use in Australia. The authors state that it is not clear whether the
reported effect of bromocriptine is causal or casual. However they urge
caution in its use, especially in women with cardiovascular risk factors
such as smoking.

Duet S, Won F, and Spurge JH,
Fatal Myocardial Infarction Associated with Bromocriptine for Postpartum
Lactation Suppression Aust. NZ Obstet Gynaecol 1998;38:1:116